Beta Bionics, Inc. · NASDAQ:BBNX

Hopman Mark sold 775 Beta Bionics, Inc. shares (Form 4)

Traded Oct 14, 2026 · Filed Oct 16, 2026

On Oct 14, 2026, Hopman Mark (Chief Commercial Officer) sold 775 Beta Bionics, Inc. shares at US$17.35 for US$13,446, leaving 55,334 shares. Filed Oct 16, 2026 (Form 4).

Sold: 775 shares
Price: US$17.35
Value: US$13,446
Holding after: 55,334 shares
Trading plan: No
Role: Chief Commercial Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 14, 2026	Common Stock	Sale	775	US$17.35	55,334	Direct

Source

Download original · View original at SEC

Related